Back to Results
First PageMeta Content
UCL Business / Imperial Innovations / Venture capital / Spin out / NHS Innovations London / Warwick Ventures / Technology / Technology transfer / Isis Innovation


Document Date: 2012-02-21 06:37:24

Open Document

File Size: 515,28 KB

Share Result on Facebook

City

Bristol / Plymouth / Oxford / Stoke-on-Trent / Southampton / Sheffield / Cambridge / Frankfurt / Paris / Manchester / Amsterdam / Maison / New York / Cardiff / London / Edinburgh / /

Company

Cellular Dynamics / Co-Managed Energy Innovation Fund / Plessey Cambridge / Archangel Directors Ltd SE / Scottish and Southern Energy / TTOs / Northstar Ventures / The Finance for Business North East / IP Group / UCB Pharma SA / UCL Business plc / Ecometrica / Isis Innovation / Rutherford Appleton Laboratories / PA Consulting / Highgate Associates / London Stock Exchange / National Grid / Metalysis / Fusion IP plc / Oxford Technology Management / TRI Capital / GlaxoSmithKline / Oxford Imaging Detectors / Strathclyde Investment Fund / Archangels / Scottish Enterprise 8 Target Development Fund / MTI Partners / Cambridge Enterprise / Sun Capital / Summit Technology / Wellcome Trust / Return Path / Cell Therapeutics / Inventages / TPP / UCL Technology / Quintiles / CamGaN / SV Life Sciences / Cambridgebased Sagentia Group plc / Nestle Alcon / Diomed Inc / /

Continent

Europe / /

Country

United Kingdom / Scotland / Switzerland / Belgium / United States / /

Currency

USD / EUR / GBP / /

/

Event

M&A / Funding / Environmental Issue / Company Expansion / Company Listing Change / Business Partnership / Labor Issues / IPO / /

Facility

Southmead Hospital / University of Dundee / Edinburgh Napier University / University of Southampton / Durham University / University College London / Staffordshire University / University of Oxford / The University of Manchester / University of Manchester / University of Strathclyde / Imperial College / Osaka University / University of Edinburgh / University of Bristol / Manchester University / In October University of Manchester / The University of Edinburgh Business School / /

IndustryTerm

technology innovation / bank loan finance / oil consumption / technology licensing / scientific imaging detectors / web platform / therapeutics renewable energy / energy savings / biopharmaceutical services / energy / stem cell technology products / large pharmaceutical/biotech / preclinical drug development programmes / technology transfer / value products / venture capital / promising technology / biotechnology / intellectual property commercialisation services / energy security / cancer treatment / innovation management / healthcare businesses / healthcare consulting services / greenhouse gas impact / electricity / art imaging instruments / consultancy services / cell bandage product / electronics / production technology / biomarker technology / restaurant chain / technology transfer transactions / defunct fermentation technology / platform technology / earlystage healthcare businesses / finance / control technologies / graphene production technology / technology originating / treatment solutions / manufacturing / continued internal development / scientific imaging / retail price / renewable products / carbon accounting system / automated semiconductor processing equipment / value sustainable products / main by-products / angel networks / high-value metals ore processing / advantages over current technology / pre-seed funding / greenhouse gas accounting / semiconductor manufacturer / luxury travel / sustainable chemicals / fermentation technology / on developing preclinical drug development programmes / /

OperatingSystem

Isis / /

Organization

Medicines Research Centre / Edinburgh Business School / Staffordshire University / University of Oxford / Durham University / Concept Fund / Napier University / University of Bristol / Faculty of Arts / Media and Design / Higher Education Innovation Fund / Orion Fund / Scottish Funding Council / Technology Licensing Office / Highgate Tech Fund / University College London / Royal Society of Chemistry / Business North East Technology Fund / PraxisUnico / University’s Department of Materials / Biofuel Research Centre / Southmead Hospital / Innovation Centre / Manchester University / Medicines and Healthcare products Regulatory Agency / University of Dundee / Technology Strategy Board / Osaka University / Royal Society of Edinburgh Commercialisation Enquiry / Target Development Fund / University of Edinburgh / University of Manchester / NHS / Yorkshire Association of Business Angels / £150m Fund / MIT in Boston / Imperial College / UMIP Premier Fund / ETH / England Development Agency / University of Southampton / /

Person

Karl Coleman / Martin Tangney / Adam J Bock / Hugh Osmond / Natasha Oppenheim / Teri Willey / David Sanderson / Gunnar Weikert / Richard Heygate / Tony Raven / Dominic Perks / Paul Ratcliff / Nick La Thangue / Angus Kirkland / Jonathan Harris / Richard Henderson / Gerry George / David Kerr / /

/

Position

CEO and Deputy Chairman / Chief Executive / leader in the industry segment / founder / CEO / Professor / Director of Research / Editor / Director of Research & Innovation Services / co-author / scientist / leader / first CEO / Lecturer / private investor / Entrepreneur / manager of angel networks / co-founder / specialist / market leader / /

Product

Orion / /

ProvinceOrState

Wisconsin / /

PublishedMedium

the Orient Express / /

SportsEvent

the heritage / /

Technology

production technology / ale / 11 Eykona Technologies / GaN-on-silicon technology / drug discovery / biofuels / semiconductor / biotechnology / enabling technologies / laser / CancerNav biomarker technology / lasers / platform technology / graphene production technology / cell therapy / fermentation technology / control technologies / defunct fermentation technology / stem cells / 06-Feb-12 Durham Graphene Science Durham £1.2m North East Technology / Adam / drug development / /

URL

www.azellon-ltd.com / http /

SocialTag